Target intelligence / Profile preview

Serine-type beta-lactamase enzyme (None)

Target
None
Molecular classification
Enzyme, Beta-Lactamase superfamily
01

Overview

Serine-type beta-lactamases are bacterial enzymes that confer resistance to beta-lactam antibiotics (such as penicillins and cephalosporins) by hydrolyzing the characteristic beta-lactam ring of these drugs, rendering them inactive. These enzymes utilize a serine residue in their active site as a nucleophile for catalysis, distinguishing them from metallo-beta-lactamases, which require metal ions. They are classified into Ambler classes A, C, and D based on sequence similarity and structural features. By breaking down β-lactams before they can inhibit cell wall synthesis enzymes (PBPs), these enzymes provide bacteria with robust resistance against many frontline antibiotics. Inhibition strategies focus on molecules that covalently modify key active-site residues or target structurally conserved regions.

02

Mechanism of action

Acylation–deacylation using nucleophilic active-site serine

03

Biological functions

Hydrolysis of beta-lactam antibioticsConferring antibiotic resistance
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Widespread antibiotic resistanceLimited effectiveness of beta-lactam antibioticsEmergence of new beta-lactamase variants
06

Interacting drugs

Penicillins

2 more in the full profile.

Beyond the preview

Go deeper on Serine-type beta-lactamase enzyme (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine-type beta-lactamase enzyme (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call